Evaluation of good clinical response to neoadjuvant chemotherapy in primary breast cancer using [18F]-fluorodeoxyglucose positron emission tomography

European Journal of Cancer

Volumn 38, Issue 3, 2002, Pages 375-379

  Burcombe, R J ^a   Makris, A ^a   Pittam, M ^b   Lowe, J ^a   Emmott, J ^a   Wong, W L ^a  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

^b LUTON AND DUNSTABLE HOSPITAL   (United Kingdom)

Author keywords

Antineoplastic agents, combined therapeutic use; Breast neoplasms drug therapy; Breast neoplasms pathology; Breast neoplasms radionuclide imaging; Fluorodeoxyglucose F 18 diagnostic use; Predictive value of tests; Tomography, emission computed methods

Indexed keywords

CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL;

ACCURACY; ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; BREAST CANCER; BREAST SURGERY; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESPONSE; DRUG UPTAKE; EVALUATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INVASIVE CARCINOMA; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SURGICAL TECHNIQUE; TREATMENT OUTCOME; TUMOR LOCALIZATION;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CARCINOMA IN SITU; CHEMOTHERAPY, ADJUVANT; CYCLOPHOSPHAMIDE; EPIRUBICIN; FEMALE; FLUORODEOXYGLUCOSE F18; FLUOROURACIL; HUMANS; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED; TREATMENT OUTCOME;

EID: 0036162122     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(01)00379-3     Document Type: Article

References (23)

1. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-18
2. Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer
3. Pathological assessment of response to induction chemotherapy in breast cancer
4. Prognostic role of clinical, pathological and biological characteristics in patients with locally advanced breast cancer
5. Treatment of large and locally advanced breast cancers using neoadjuvant chemotherapy
6. Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma
7. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer
8. Assessment of the effect of pretreatment with neoadjuvant therapy on primary breast cancer
9. Sonographic, magnetic resonance imaging, and mammographic assessments of preoperative size of breast cancer
10. Gamma emission imaging in the management of breast disorders
11. Evaluation of preoperative chemotherapy using PET with fluorine-18-fluorodeoxyglucose in breast cancer
12. Primary and metastatic breast carcinoma: Initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose
13. Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: Initial evaluation
14. Positron emission tomography: 2-deoxy-2-[18F]-fluoro-D-glucose uptake in locally advanced breast cancers
15. Positron emission tomography studies in patients with locally advanced and/or metastatic breast cancer: A method for early therapy evaluation?
16. Positron emission tomography using [(18)F]-fluorodeoxy-D-glucose to predict the pathologic response of breast cancer to primary chemotherapy
17. Positron emission tomography using [(18)F] Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer
18. Reporting results of cancer treatment
19. Neoadjuvant chemotherapy, locally advanced breast cancer, and quality of life
20. Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: Use and limitations
21. Primary breast cancer: Mammographic changes after neoadjuvant chemotherapy, with pathologic correlation
22. Locally advanced breast carcinoma: Accuracy of mammography versus clinical examination in the prediction of residual disease after chemotherapy
23. Use of positron emission tomography in evaluation of brachial plexopathy in breast cancer patients